Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disability status and dental pathology in multiple sclerosis patients.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.
Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.
Fingolimod and cardiac risk: latest findings and clinical implications.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.
The role of myelin and oligodendrocytes in axonal energy metabolism.
Impact of Ongoing National Health Technology Assessment Challenges on Patient Access to New Therapies for Multiple Sclerosis In Germany And The Uk.
Axon-to-Glia Interaction Regulates GabaA Receptor Expression in Oligodendrocytes.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Prefrontal tDCS Decreases Pain in Patients with Multiple Sclerosis.
Multiple sclerosis drugs: Sticker shock.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
CCR5 blockade for neuroinflammatory diseases - beyond control of HIV.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
[One case of pediatric multiple sclerosis with convulsions as initial symptoms].
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.
Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Pages
« first
‹ previous
…
665
666
667
668
669
670
671
672
673
…
next ›
last »